AELIX THERAPEUTICS
Aelix Therapeutics develops therapeutic vaccines and immunotherapies to treat HIV infection. The company is a spin-off of HIVACAT, the Catalan project for the development of effective vaccines against HIV. The company was created under the leadership of its founders, Dr. Christian Brander, Bonaventura Clotet, Josep Maria Gatell and Mr. Jordi Naval; all of whom have several decades of experience in HIV and biotech development. The company’s know-how will further expand through unique immunogen designs. It will also benefit from ready access to large cohorts of HIV infected patients in several continents through its partnership with the HIVACAT consortium.
AELIX THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2014-01-01
Address:
Barcelona, Catalonia, Spain
Country:
Spain
Website Url:
http://www.aelixtherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
(514) 367 1212
Email Addresses:
[email protected]
Total Funding:
13.41 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Google Tag Manager WordPress Google Universal Analytics Apache
Similar Organizations
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Elicio Therapeutics
Elicio Therapeutics develops an immuno-tumor vaccine to treat cancer.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Spero Therapeutics
Spero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections.
Current Advisors List
Current Employees Featured
Founder
Investors List
CDTI
CDTI investment in Venture Round - Aelix Therapeutics
Ysios Capital
Ysios Capital investment in Venture Round - Aelix Therapeutics
Caixa Capital Risc
Caixa Capital Risc investment in Venture Round - Aelix Therapeutics
EIT Health
EIT Health investment in Grant - Aelix Therapeutics
Caixa Capital Risc
Caixa Capital Risc investment in Series A - Aelix Therapeutics
Ysios Capital
Ysios Capital investment in Series A - Aelix Therapeutics
Johnson & Johnson Innovation
Johnson & Johnson Innovation investment in Series A - Aelix Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2021-05-18 | AELIX Therapeutics appoints Dr Melanie Rolli as CEO |
Official Site Inspections
http://www.aelixtherapeutics.com Semrush global rank: 6.09 M Semrush visits lastest month: 1.33 K
- Host name: llhm307.servidoresdns.net
- IP address: 217.76.149.19
- Location: Spain
- Latitude: 40.4172
- Longitude: -3.684
- Timezone: Europe/Madrid
